Metraipolis › archive › dc_35466faca4df

Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry — Europe PMC PMID:40932389

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40932389
DOI
10.1128/spectrum.02777-24
License (as archived)
solo-consultazione
Archived
2026-10-08T01:07:47.189Z
SHA-256 of the archived text
f2b6af0de89b8d8a2a12751bb8dfdf1e2c501d0e48aeba7ebbbebf51baabd5b2
Stable URL of this page
https://metraipolis.com/documento/dc_35466faca4df

How to cite

Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry — Europe PMC PMID:40932389 — Europe PMC (en), https://europepmc.org/article/MED/40932389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35466faca4df (Metraipolis archive dc_35466faca4df, sha256 f2b6af0de89b8d8a2a12751bb8dfdf1e2c501d0e48aeba7ebbbebf51baabd5b2)
BibTeX
@misc{dc35466faca4df,
  title = {Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry — Europe PMC PMID:40932389},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40932389},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35466faca4df; sha256 f2b6af0de89b8d8a2a12751bb8dfdf1e2c501d0e48aeba7ebbbebf51baabd5b2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40932389. Agents can read the archived copy with the MCP tool read_document.